Tag: $Eli Lilly

Lilly’s diabetes drug Mounjaro approved by UK watchdog

 Eli Lilly’s diabetes drug Mounjaro has gained the backing of Britain’s healthcare cost-effectiveness watchdog, which said it would be a good option for patients with poorly controlled type 2 diabetes.

Eli Lilly Stock Is Flying After Strong Results. Obesity Drugs Delivered the Goods.

Eli Lilly stock was flying on Tuesday after the drugmaker recorded quarterly profit and revenue well ahead of Wall Street’s expectations. Sales of obesity drugs are delivering the goods.

Eli Lilly’s obesity drug succeeds in two late-stage studies

July 27 (Reuters) – Eli Lilly (LLY.N) said on Thursday its experimental obesity drug met the main goals in two late-stage studies, with the drug helping patients reduce 26.6% weight on average in one of the studies following intensive lifestyle changes.

Eli Lilly experimental obesity drug could beat rivals in total weight loss for patients

Eli Lilly’s experimental drug helped patients lose up to 24% of their weight after almost a year, the highest reduction seen in the obesity treatment space to date, according to new mid-stage clinical trial results released Monday.

Eli Lilly to Buy DICE Therapeutics in $2.4 Billion Autoimmune Disease Push

Eli Lilly has agreed to buy DICE Therapeutics in a $2.4 billion cash deal that reflects Lilly’s ambitions in immunology, a hot market where the company has lagged behind its coompetitors.